Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential of Immune Checkpoint Blockade in Cervical Cancer: Can Combinatorial Regimens Maximize Response? A Review of the Literature
Lennox Chitsike, Penelope J. Duerksen-Hughes
Current Treatment Options in Oncology (2020) Vol. 21, Iss. 12
Closed Access | Times Cited: 21

Showing 21 citing articles:

Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas
Zhiheng Lin, Jiani Zou, Xiaohui Sui, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 39
Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis
Jiawen Kang, Jingwen Jiang, Xiaoqing Xiang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
T cell immunotherapy for cervical cancer: challenges and opportunities
Lingfeng Yu, Gong Lanqing, Ziyu Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System
Melania Dovizio, Patrizia Ballerini, Rosa Fullone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9585-9585
Open Access | Times Cited: 45
B2M and JAK1/2–mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy
Chenzhi Zhang, Dandan Li, Binyi Xiao, et al.
Journal of Immunotherapy (2022) Vol. 45, Iss. 4, pp. 187-193
Open Access | Times Cited: 23
The immune landscape during the tumorigenesis of cervical cancer
Yiying Wang, Mengdi He, Guodong Zhang, et al.
Cancer Medicine (2021) Vol. 10, Iss. 7, pp. 2380-2395
Open Access | Times Cited: 28
The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer
Bertha Alejandra Martínez-Cannon, Ilaria Colombo
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
Giuseppe Schepisi, Chiara Casadei, I. Toma, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 840-840
Open Access | Times Cited: 24
Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy
Shijie Yao, Liyang Zhao, Siming Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis
Zhichao Wang, Long Cheng, Guanghui Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advances in systemic treatment for recurrent metastatic cervical cancer
Gyeong Hoon Kang, Weimin Du, Shu Zeng, et al.
British Journal of Hospital Medicine (2024), pp. 1-10
Closed Access | Times Cited: 2
PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6
Lennox Chitsike, Penelope J. Duerksen-Hughes
Molecules (2021) Vol. 26, Iss. 10, pp. 3004-3004
Open Access | Times Cited: 12
Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review
Nika Nikmanesh, SeyedehZahra Hosseini, Fatemehsadat Mirbagheri, et al.
Viral Immunology (2024) Vol. 37, Iss. 5, pp. 221-239
Closed Access | Times Cited: 1
A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas
Lennox Chitsike, Chung-Hsiang Yuan, Anuradha Roy, et al.
Oncotarget (2021) Vol. 12, Iss. 6, pp. 549-561
Open Access | Times Cited: 8
Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
Lennox Chitsike, Penelope J. Duerksen-Hughes
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
B7 homolog 6 promotes the progression of cervical cancer
Ruimeng Guo, Guoyan Liu, Changying Li, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review
Nathália Alves Araújo de Almeida, Camilla Rodrigues de Almeida Ribeiro, Jéssica Vasques Raposo, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 822-822
Open Access | Times Cited: 3
B7-H6 promotes the killing activity of NK cells against cervical cancer through the downstream ERK pathway of NKp30
Ruimeng Guo, Ou Chai, Changying Li, et al.
Research Square (Research Square) (2023)
Open Access
Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma
Chunxiao Yan, Yanyan Ma, Junyan Li, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Tumour-agnostic immunotherapy for rare and uncommon cancers: The patient’s dilemma
Robert W. Tindle
Australian Journal of General Practice (2023) Vol. 52, Iss. 12, pp. 889-892
Open Access
A Novel Ferroptosis-Related lncRNA Signature and an Immune Perspective of Cervical Cancer
Pengxiang Li, Dongchun Qin, Xuefeng Lv, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top